Wednesday - May 15, 2024
Ropes & Gray Advises on 3 of the Top 10 Biopharmaceutical Licensing Deals in 2023
March 27, 2024
BOSTON, Massachusetts, March 27 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray represented clients in three of the top 10 and four of the top 20 biopharmaceutical licensing deals measured by deal value, according to an analysis by DealForma. Ropes & Gray licensing partners advised clients in these top deals for an aggregate value of $14.7 billion. Among the deals Ropes & Gray was involved in were the following:

* Pfizer in a strategic . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products